The prevalence of aPL is higher in patients with other autoimmune conditions such as rheumatoid arthritis or systemic lupus erythematosus (SLE), where up to 40 % are persistently positive for aPL [10, 11]. This evidence concerns the gene FASLG and systemic lupus erythematosus.